Table 1 Population characteristics.

From: Late first trimester circulating microparticle proteins predict the risk of preeclampsia < 35 weeks and suggest phenotypic differences among affected cases

Characteristic

Preeclampsia

(N = 23)

Controls

(N = 50)

p valuea

Median (IQR) or N (%)

Median (IQR) or N (%)

 

Maternal age

32.3 (28.1–36.6)

31.3(26.2–36.9)

0.63

Maternal race

  

0.74

 Black

6 (26.0%)

14 (28.0%)

 

 Hispanic

2 (8.7%)

10 (20.0%)

 

 White, non-Hispanic

15 (65.2%)

26 (52.0%)

 

Nullipara

5 (22.0%)

14 (28.0%)

0.42

Smoking

4 (17.4%)

10 (20.0%)

0.79

Married

16 (70.0%)

31 (62.0%)

0.89

Chronic hypertension

3 (13.0%)

0 (0.0%)

0.009

Chronic renal disease/proteinuria

0 (0.0%)

0 (0.0%)

NA

Pre pregnancy BMI

24.6 (21.1–29.1)

25.5 (22.5–30.0)

0.74

PE in prior pregnancy

6 (33.3%)

3 (8.3%)

0.02

Prior spontaneous PTB

12 (66.7%)

8 (22.2%)

0.001

Gestational age (weeks) at

 Sampling

11.3 (8.7–13.4)

11.1 (9.6–13.7)

0.97

 Delivery

34.4 (32.0–35.3)

39.4 (38.9–40.4)

< 0.001

Birth metrics (g)

 Birth weight

2215 (1400–2811)

3353 (3140–3725)

< 0.001

 Z-score

− 0.24 (− 1.1–0.6)

− 0.21 (− 0.7–0.8)

0.45

Infant gender

 Female

15 (65.2%)

26 (52.0%)

0.29

 Male

8 (34.8%)

24 (48.0%)

 

Clinical characteristics

 Median maximum systolic (mmHg)

168 (147–180)

112 (103–120)

< 0.001

 Median maximum diastolic (mmHg)

96 (88–99)

68 (61–73)

< 0.001

 Median 24 h protein (gram)

581 (343–921)

NA

NA

 Week of PE diagnosis

32.4 (29.7–33.0)

NA

NA

  1. ap values calculated with Wilcoxon Rank Sum test, ANOVA, Chi Square test, or Fisher Exact test where appropriate.
  2. NA not applicable/available.